Trastuzumab

Dr. Reddy’s Laboratories announces the launch of Hervycta® (trastuzumab biosimilar) in India

Mumbai, July 28, 2018: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY) announced today that it has launched Hervycta® (Trastuzumab), a…

6 years ago

Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis

New Delhi, May 18, 2018: Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis The…

7 years ago

Biocon, Mylan’s Biosimilar Trastuzumab gets ANVISA’s approval

Mumbai, Janaury 04, 2018: Biotechnology mAJOR, Biocon and Mylan have received approval for Biosimilar Trastuzumab from ANVISA, the Brazilian regulatory agency,…

7 years ago